0RGI vs LCLA: Side-by-Side Comparison
Compare COSMO Pharmaceuticals SA (0RGI) and PT Kalbe Farma Tbk (LCLA) side by side: valuation, financials, growth and model signals on Bullrun.
| Metric | 0RGI | LCLA |
|---|---|---|
| Company | COSMO Pharmaceuticals SA | PT Kalbe Farma Tbk |
| Country / Exchange | Ireland · LSE | Indonesia · F |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Market cap | — | EUR 2.13B |
| P/E ratio | 50.2 | — |
| Dividend yield | — | 2.93% |
| Valuation model | — | — |
| Revenue (latest FY) | GBP 104.17M | — |
| Revenue growth YoY | -61.0% | — |
| Net income | GBP -3.61M | — |
| Gross margin | 48.5% | — |
| Diluted EPS | — | — |